Influence of genetic polymorphisms in GSTM1, GSTM3, GSTT1 and GSTP1 on allograft outcome in renal transplant recipients

Clinical Transplantation

Volumn 23, Issue 4, 2009, Pages 490-498

  Singh, Ranjana ^a   Manchanda, Parmeet K ^a   Kesarwani, Pravin ^a   Srivastava, Aneesh ^a   Mittal, Rama D ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Glutathione S transferases; Multiplex PCR; PCR RFLP; Rejection episode; Renal transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE M3; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL RISK;

ADULT; CASE-CONTROL STUDIES; DELAYED GRAFT FUNCTION; FEMALE; GENE FREQUENCY; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; INDIA; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 68349130322     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2009.00985.x     Document Type: Article

References (25)

1. Sundberg AG, Appelkvist EL, Bäckman L, Dallner G. Urinary pi-class glutathione transferase as an indicator of tubular damage in the human kidney. Nephron 1994: 67: 308.
2. Sheehan D, Meade G, Foley VM, Dowd CA. Structure, function and evolution of glutathione transferases: Implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 2001: 360: 1.
3. Kharbanda R, Lauder J, Thomson D, Gouldesbrough DR, Harrison DJ. Heterogeneity of glutathione S-transferase isoenzyme expression in renal disease. Nephrol Dial Transplant 1991: 6: 695.
4. Strange RC, Fryer AA. The glutathione S-transferases: Influence of polymorphismon susceptibility to non familial cancers. In: B offetta P, C aporaso N, C uzick J, L ang M, V ineis P eds. Metabolic Polymorphisms and Cancer. Lyon: IARC Scientific Publications, 1999: 303.
5. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 2000: 61: 154.
6. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1997: 6: 733.
7. Ali-Osman F, Akande O, Antoun G, Mao JX, Buolamwini J. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins. J Biol Chem 1997: 272: 10004.
8. Inskip A, Elexperu-Camiruaga J, Buxton N et al. Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: Evidence for linkage with GSTM1*A. Biochem J 1995: 15: 713.
9. Racusen LC, Solez K. Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999: 55: 713.
10. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
11. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 1998: 22: 129.
12. Harries LW, Stubbins MJ, Forman D, Howard GC, Wolf CR. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis 1997: 18: 641.
13. Campistol JM, Sacks SH. Mechanisms of nephrotoxicity. Transplantation 2000: 69: SS5.
14. Satyanarayana PS, Chopra K. Oxidative stress-mediated renal dysfunction by cyclosporine A in rats: Attenuation by trimetazidine. Ren Fail 2002: 24: 259.
15. Suleymanlar G, Suleymanlar I, Shapiro JI, Chan L. Possible role of lipid peroxidation in cyclosporine nephrotoxicity in rats. Transplant Proc 1994: 26: 2888.
16. Wolf A, Clemann N, Frieauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporin-A-mediated impairment of renal functions. Transplant Proc 1994: 26: 2902.
17. Sung H, Nah J, Chun S, Park H, Yang SE, Min WK. In vivo antioxidant effect of green tea. Eur J Clin Nutr 2000: 54: 527.
18. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 2005: 48: 339.
19. Wang BG, Chen SD, Zhou WP et al. A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer. Zhonghua Zhong Liu Za Zhi 2004: 26: 93.
20. Dong C, Yang Q, Wang M, Dong Q. A study on the relationship between polymorphism of CYP1A1, lack of GSTM1, and susceptibility to lung cancer. J Occup Environ Med 2004: 21: 440.
21. Liang GY, Pu YP, Yin LH. Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Yi Chuan 2004: 26: 584.
22. Jain M, Kumar S, Lal P, Tiwari A, Ghoshal UC, Mittal B. Role of GSTM3 polymorphism in the risk of developing esophageal cancer. Cancer Epidemiol Biomarkers Prev 2007: 16: 178.
23. Agrawal S, Tripathi G, Khan F, Sharma R, Baburaj VP. Relationship between GSTs gene polymorphism and susceptibility to end stage renal disease among north Indians. Ren Fail 2007: 29: 947.
24. Polak WP, Kosieradzki M, Kwiatkowski A et al. Activity of glutathione S-transferases in the urine of kidney transplant recipients during the first week after transplantation. Ann Transplant 1999: 4: 42.
25. Yang Y, Kao MT, Chang CC et al. Glutathione S-transferase T1 deletion is a risk factor for developing end-stage renal disease in diabetic patients. Int J Mol Med 2004: 14: 855.